On Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on shares of Arcturus Therapeutics (NASDAQ:ARCT), currently trading at $11.59. Following the company’s release of its first-quarter ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

On Tuesday, Cantor Fitzgerald reaffirmed a Neutral rating on Polestar Automotive Holding UK Plc (NASDAQ:PSNY), following the company’s announcement on May 12 to pause its financial guidance for ...

May 8 (Reuters) - Swiss lender UBS (UBSG.S), opens new tab is in talks to sell its hedge fund unit, O'Connor, to U.S. brokerage Cantor Fitzgerald, Bloomberg News reported on Thursday, citing ...

Cantor Fitzgerald is set to launch a $3 billion Bitcoin investment initiative in collaboration with SoftBank, Tether, and Bitfinex, according to a report by the Financial Times. The project ...

UBS Group is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald, according to people familiar with the matter. The deal could involve a possible revenue sharing agreement ...

Cantor Fitzgerald analyst Steve Seedhouse assumed coverage of ProQR Therapeutics (PRQR) with an Overweight rating and $8 price target ProQR is a leader in RNA editing and the initial biomarker ...

Brandon Lutnick, chair of investment banking firm Cantor Fitzgerald, is reportedly partnering with SoftBank, Tether and Bitfinex to create a $3 billion crypto acquisition company. Lutnick and the ...

This week’s Crypto Biz newsletter covers renewed inflows into Bitcoin ETFs, a potential crypto venture backed by Cantor Fitzgerald, and Coinbase’s possible pursuit of a federal banking charter.

Cantor Fitzgerald, SoftBank Group, Tether, and Bitfinex have joined hands to launch Twenty One. The consortium of traditional finance (TradFi) and decentralized finance (DeFi) firms announced on ...

Brandon Lutnick, chairman of Cantor Fitzgerald and son of U.S. Commerce Secretary Howard Lutnick, is leading a significant Bitcoin investment initiative. The venture will operate under a new ...

Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Annexon Biosciences (NASDAQ:ANNX), focusing on the biopharmaceutical company’s upcoming regulatory filings and clinical data. Analysts at ...